We previously developed a suicide-therapy approach for rhabdomyosarcoma in which the promoter region of MYOG (highly expressed in rhabdomyosarcoma) was modified to enhance rhabdomyosarcoma-specificity. Here, MYOG is linked to rhabdomyosarcoma.